• Resumen
  • Sinónimos
  • Subdivisiones
  • Signos y Síntomas
  • Causas y Herencia
  • Frecuencia
  • Enfermedades con síntomas similares
  • Diagnóstico
  • Tratamiento
  • Investigaciones
  • Referencias
  • Programas & Recursos
  • Informe completo

Atrioventricular Septal Defect

Imprimir

Última actualización: September 14, 2022
Años publicados: 1986, 1994, 2005


Resumen

Atrioventricular septal defect (AVSD) is a general term for a group of rare heart defects that are present at birth (congenital). Infants with AVSDs have improperly developed atrial and ventricular septa and adjoining valves.

The normal heart has four chambers. The two upper chambers, known as atria, are separated from each other by a fibrous partition called the atrial septum. The two lower chambers, known as ventricles, are separated from each other by the ventricular septum. Valves (e.g., mitral and tricuspid) connect the atria (left and right) to their respective ventricles. The valves allow for blood to be pumped through the chambers. Blood travels from the right ventricle through the pulmonary artery to the lungs where it receives oxygen. The blood returns to the heart through pulmonary veins and enters the left ventricle. The left ventricle sends the now oxygen-filled blood into the main artery of the body (aorta). The aorta sends the blood throughout the body.

The parts of the heart described above are formed from an embryonic structure called the endocardial cushions. In individuals with AVSD there is some combination of malformation of these parts of the heart. They may include a hole in the atrial septum, a hole in the ventricular septum, and/or abnormalities of the mitral and triscupid valves. AVSD may be classified as one of three forms: an incomplete (or partial) AVSD (atrial septal defect primum); a transitional form (atrial septal defect and small ventricular septal defect); or a more severe or complete form (large atrial and ventricular defects).

The symptoms of AVSD vary greatly and depend on the severity of the malformations (e.g., valve leakage between ventricles and ventricular size). About half the cases of AVSD occur in children with Down syndrome.

  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Sinónimos

  • Atrioventricular Canal Defects
  • AVSD
  • Common Atrioventricular Canal (CAVC) Defect
  • Endocardial Cushion Defects
  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Subdivisiones

  • Complete Atrioventricular Septal Defect
  • Incomplete Atrioventricular Septal Defect
  • Partial Atrioventricular Septal Defect
  • Transitional Atrioventricular Septal Defect
  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Signos y Síntomas

Infants with the complete form of atrioventricular septal defect usually develop a limited ability to circulate blood to the lungs and the rest of the body resulting in fluid buildup in the heart, lung and various body tissues (congestive heart failure). Pulmonary congestion may lead to difficulty breathing (dyspnea) and fatigue. Infants with complete atrioventricular septal defect often have a bluish discoloration of the skin and mucous membranes (cyanosis) due to insufficient oxygen supply to these tissues.

Other symptoms that may occur in all forms of AVSD include poor feeding, abnormally rapid breathing (tachypnea), excessive sweating, and/or an abnormally rapid heartbeat (tachycardia).

Frequent episodes of acute inflammation of the lungs (pneumonia) and bronchial tubes (bronchitis) are common in children with all forms of AVSD. Abnormally high pressure within the artery that leads to the heart from the lungs (pulmonary artery) may impair lung function and result in permanent pulmonary vascular disease before the age of 1 year. Some more severely affected infants may have congestive heart failure as a direct result of these serious complications.

Older children with untreated AVSD may be at risk for brain abscesses, the development of blood clots (thrombosis) that may travel and lodge in the arteries (embolism), and/or acute inflammation of the inner membranes that line the heart (bacterial endocarditis).

Adults with AVSD who have not had surgery to correct this heart defect may develop Eisenmenger syndrome. This is a rare disorder characterized by restricted blood flow between the lungs and the heart that occurs because of a ventricular septal defect. Symptoms of this condition may include abnormally low blood pressure, irregular heartbeats, and/or rapid heart rate. (For more information on this disorder, choose “Eisenmenger” as your search term in the Rare Disease Database.)

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Causas y Herencia

The exact cause of atrioventricular septal defect is not known (idiopathic). This birth defect can occur alone with no apparent cause (sporadically), or it can occur in association with other disorders such as Down syndrome.

Researchers believe that, in cases of isolated AVSD, environmental, genetic, and/or other factors (multifactorial) may be involved in some way.

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Frecuencia

Atrioventricular septal defect affects males and females in equal numbers. Approximately 50 percent of cases occur in association with other disorders, especially Down syndrome. AVSD may also occur with other congenital heart defects, in 10 percent of cases it occurs in association with patent ductus arteriosus or tetralogy of Fallot. (For more information on these disorders, choose the exact disorder name as your search term in the Rare Disease Database.)

The exact incidence of AVSD in the general population is unknown. The complete form of AVSD occurs more often than the partial or transitional forms. Approximately 75 percent of cases of complete AVSD occur in individuals with Down syndrome. Most cases of partial AVSD do not occur in individuals with Down syndrome.

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Diagnóstico

The diagnosis of atrioventricular septal defect can be made by imaging techniques of the heart such as magnetic resonance imaging (MRI) and echocardiogram (EC). In another procedure known as a cardiac catheterization, a long fine tube (catheter) is inserted into a large vein and then channeled directly into the heart. This allows the physician to determine the extent of the defect (i.e., complete, transitional, or incomplete) and to determine the rate of blood flow through the heart. Angiography is another useful diagnostic procedure and allows the physician to view an enhanced x-ray of the heart. Children with AVSD typically have an abnormal EKG reading.

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Tratamiento

Treatment

Infants with AVSD should be referred to a hospital that can perform sophisticated diagnostic procedures and cardiovascular surgery. Infants with AVSD generally require surgery at a young age, usually before the age of 6 to 12 months.

Prior to surgery, congestive heart failure associated with AVSD may be managed by reducing fluid volume with diuretic drugs and, if necessary, the dietary restriction of fluids and salt. The drug digoxin may also be administered to decrease the heart rate and increase the strength of the heart's contractions. Oxygen therapy and adequate nutrition may also prove beneficial.

Because children with AVSD are susceptible to bacterial infection of the membranes that surround the heart (endocarditis), any respiratory infection should be treated vigorously and early. Affected individuals should also be given antibiotics before invasive dental procedures (e.g., root canal or extractions) or other surgical procedures to help prevent potentially life-threatening infections.

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Investigaciones

Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government website.

For information about clinical trials being conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:

Tollfree: (800) 411-1222

TTY: (866) 411-1010

Email: [email protected]

For information about clinical trials sponsored by private sources, contact:

www.centerwatch.com

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Referencias

TEXTBOOKS

Lange A, Palka P. Atrioventricular Septal Defects. In: NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:43-4.

Cecil Textbook of Medicine, 19th Ed.: James B. Wyngaarden and Lloyd H. Smith, Jr., Editors; W.B. Saunders Co., 1992. Pp. 280-84.

The Merck Manual, 16th Ed.: Robert Berkow, Editor; Merck Research Laboratories, 1992. Pp. 2051-55.

Birth Defects Encyclopedia, Mary Louise Buyse, Editor-In-Chief; Blackwell Scientific Publications, 1990. Pp. 209-10.

Nelson Textbook of Pediatrics, 14th Ed.; Richard E. Behrman et al.; W.B. Saunders Co., 1992. Pp. 1169-70.

JOURNAL ARTICLES

Dunlop KA, Mulholland HC, Casey FA, Craig B, Gladstone DJ. A ten year review of atrioventricular septal defects. Cardiol Young. 2004;14:15-23.

Pretre R, Dave H, Kadner A, Bettex D, Turina MI. Direct closure of the septum primum in atrioventricular canal defects. J Thorac Cardiovasc Surg. 2004;127:1678-81.

Maslen CL. Molecular genetics of atrioventricular septal defects. Curr Opin Cardiol. 2004;19:105-10.

Mahoney LT. Acyanotic congenital heart disease. Atrial and ventricular septal defects, atrioventricular canal, patent ductus arteriosus, pulmonic stenosis. Cardiol Clin. 1993;11:603-16.

Lozano C., et al., Surgery of atrioventricular septal defects. Review of the first 100 cases. Eur J Cardiothorac Surg. 1990;4:359-64.

Cheng TO. Cardiac failure in coronary heart disease. Am Heart J. 1990;120:396-412.

Ilbawi MN. Current status of surgery for congenital heart diseases. Clin Perinatol. 1989;16:157-76.

  • < Sección anterior
  • Sección siguiente >

Programas & Recursos

Programas de asistencia RareCare®

Programas de Asistencia Adicional

Programa de Asistencia MedicAlert

NORD y la Fundación MedicAlert se han asociado en un nuevo programa para brindar protección a pacientes con enfermedades raras en situaciones de emergencia.

Aprende más https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/

Programa de Apoyo Educativo de Enfermedades Raras

Asegurarse de que los pacientes y los cuidadores estén equipados con las herramientas que necesitan para vivir su mejor vida mientras manejan su condición rara es una parte vital de la misión de NORD.

Aprende más https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/

Programa de descanso para cuidadores raros

Este programa de asistencia, primero en su tipo, está diseñado para los cuidadores de un niño o adulto diagnosticado con un trastorno raro.

Aprende más https://rarediseases.org/patient-assistance-programs/caregiver-respite/

Organizaciones de pacientes


More Information

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report
Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report
National Organization for Rare Disorders